Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence From a Household Cohort Study in England and Wales: ERRATUM
For the article “Prevalence and Characteristics of Persistent Symptoms in Children During the COVID-19 Pandemic: Evidence From a Household Cohort Study in England and Wales”1 that appeared on pages 979-984 of volume 41, issue 12, December 2022 issue of The Pediatric Infectious Disease Journal, there were errors with the citations for the Tables and the Supplement Digital Content links which have now been corrected in the online version. Most notably, Table 2 was missing in the original version, and it is now available online and below. The publisher regrets the errors.
Table 2. -
Prevalence of persistent symptoms according to risk factors and adjusted odds ratios (aORs), n = 5032.
Variable
Persistent symptom prevalence
n/N (%)
aOR (95% CI)
Age group
<2 years
8/353 (2.3)
1.77 (0.68 - 4.62)
2-11 years
48/2,749 (1.8)
1
12-17 years
73/1,930 (3.8)
2.59 (1.55 - 4.32)
Gender
Male
56/2,238 (2.5)
1
Female
67/2,031 (3.3)
1.51 (0.95 - 2.40)
Missing
6/763 (0.8)
0.23 (0.06 - 0.90)
IMD Quintile
1
10/480 (2.1)
0.64 (0.24 - 1.70)
2
21/730 (2.9)
0.94 (0.44 - 2.01)
3
26/923 (2.8)
0.92 (0.45 - 1.85)
4
24/1,133 (2.1)
0.59 (0.29 - 1.20)
5
45/1,466 (3.1)
1
Missing
3/300 (1.0)
Long term condition reported
No
102/4,534 (2.3)
1
Yes
27/498 (5.4)
2.55 (1.36 - 4.80)
History of SARS-CoV-2 infection
No
86/3,970 (2.2)
1
Yes◦
43/1,062 (4.1)
1.81 (1.08 - 3.05)
1. Miller F, Nguyen V, Navaratnam A, et al. Prevalence and characteristics of persistent symptoms in children during the COVID-19 pandemic: evidence from a household cohort study in England and Wales. Pediatr Infect Dis J. 2022;41:979–984.
Comments (0)